Alltracel forms joint venture with nanofibre specialist
This article was originally published in Clinica
Executive Summary
Irish woundcare specialist Alltracel Pharmaceuticals and its Czech Republic R&D partner Elmarco have formed a joint venture to commercialise the latter's nanofibre manufacturing technology to the professional and consumer wound care markets.